The continuous stream of drug approvals by Chinese pharmaceutical companies should be a source of awe to any global innovation investor. There are multiple reasons that have led to the current point. However, one key contributor is China’s drug approval policy transformation, which is one of the most under-discussed and massively impactful policy narratives of […]
Category: China
China is the epicenter of Asia and the core of Asia Times news coverage. Our China reportage covers everything from the Belt and Road Initiative to the tech and chip wars to the rising threat of war with the United States. With a hard focus on China’s economy, finance, trade, technology and military, Asia Times provides trenchant insight into China’s rising challenge to the old world order.
